A randomized, double-blind, vehicle-controlled trial evaluating the efficacy and safety of a topical siRNA-based formulation targeting DKK-1 (Dickkopf-1) in patients with androgenetic alopecia (AGA).
The full text of this paper was not available for review; specific outcome data, sample size, duration, and statistical results cannot be confirmed or reported.
